MarketCap
Facebook
X
TelegramQuarterly report 2022-Q2
added 12-16-2023
Covetrus ROE Ratio 2011-2025 | CVET
Annual ROE Ratio Covetrus
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.57 | -1.24 | -78.21 | 6.96 | 5.27 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.96 | -78.21 | -14.16 |
Quarterly ROE Ratio Covetrus
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.66 | -0.66 | -0.93 | -2.73 | -3.38 | -3.64 | -5.85 | -0.28 | -1.98 | -4.67 | -77.58 | -81.54 | -79.9 | -74.68 | 1.78 | 4.17 | 6.83 | 4.55 | 3.48 | 1.54 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 6.83 | -81.54 | -15.81 |
ROE Ratio of other stocks in the Health information services industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cerner Corporation
CERN
|
15.1 | - | - | $ 27.9 B |  USA |
 |
Computer Programs and Systems
CPSI
|
-24.54 | - | 4.4 % | $ 133 M | USA |
 |
Accolade
ACCD
|
-12.96 | - | 0.29 % | $ 206 M | USA |
 |
Castlight Health, Inc.
CSLT
|
-50.2 | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
7.4 | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
3.19 | - | - | $ 6.37 B | USA |
 |
iCAD
ICAD
|
-19.58 | - | - | $ 102 M | USA |
 |
Change Healthcare
CHNG
|
-1.75 | - | - | $ 9.03 B | USA |
 |
Evolent Health
EVH
|
-2.23 | $ 3.98 | -1.85 % | $ 373 M | USA |
 |
Health Catalyst
HCAT
|
-19.03 | $ 2.36 | -1.05 % | $ 142 M | USA |
 |
HealthStream
HSTM
|
5.57 | $ 23.17 | -0.45 % | $ 704 M | USA |
 |
MTBC
MTBC
|
15.77 | - | -0.58 % | $ 51.7 M | USA |
 |
Akerna Corp.
KERN
|
303.85 | - | - | $ 161 M | USA |
 |
HealthEquity
HQY
|
1.3 | $ 92.07 | -0.46 % | $ 7.88 B | USA |
 |
Progyny
PGNY
|
2.5 | $ 25.83 | -0.04 % | $ 2.22 B | USA |
 |
American Well Corporation
AMWL
|
-68.29 | $ 4.61 | -3.96 % | $ 69.1 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
9.55 | - | -10.39 % | $ 886 M | USA |
 |
OptimizeRx Corporation
OPRX
|
-13.88 | $ 12.21 | -1.45 % | $ 209 M | USA |
 |
So-Young International
SY
|
-32.05 | $ 2.59 | 2.58 % | $ 206 M |  China |
 |
Schrödinger
SDGR
|
-44.4 | $ 17.79 | -0.06 % | $ 1.29 B | USA |
 |
GoodRx Holdings
GDRX
|
2.26 | $ 2.73 | 1.3 % | $ 1.05 B | USA |
 |
Omnicell
OMCL
|
1.01 | $ 45.35 | -1.24 % | $ 2.09 B | USA |
 |
1Life Healthcare
ONEM
|
-14.73 | - | - | $ 3.37 B | USA |
 |
10x Genomics
TXG
|
-34.42 | $ 16.39 | 0.61 % | $ 1.92 B | USA |
 |
Phreesia
PHR
|
-54.44 | $ 16.88 | -0.88 % | $ 921 M | USA |
 |
Premier
PINC
|
1.17 | $ 28.26 | - | $ 2.33 B | USA |
 |
R1 RCM
RCM
|
28.04 | - | - | $ 3.81 B | USA |
 |
NantHealth
NH
|
30.07 | - | -46.64 % | $ 10.4 M | USA |
 |
NextGen Healthcare
NXGN
|
2.2 | - | - | $ 1.6 B | USA |
 |
Zhongchao
ZCMD
|
-3.09 | $ 0.44 | -27.52 % | $ 2.29 M | China |
 |
Signify Health
SGFY
|
-70.29 | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
-82.75 | - | - | $ 21.4 M | USA |
 |
Teladoc Health
TDOC
|
-67.15 | $ 6.94 | -0.79 % | $ 1.18 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
258.65 | - | - | $ 255 M | USA |
 |
Veeva Systems
VEEV
|
11.32 | $ 223.31 | -0.59 % | $ 35.8 B | USA |
 |
SCWorx Corp.
WORX
|
-25.31 | $ 0.19 | -2.75 % | $ 277 K | USA |